BR112014009580A2 - composição farmacêutica de omeprazol - Google Patents

composição farmacêutica de omeprazol

Info

Publication number
BR112014009580A2
BR112014009580A2 BR112014009580A BR112014009580A BR112014009580A2 BR 112014009580 A2 BR112014009580 A2 BR 112014009580A2 BR 112014009580 A BR112014009580 A BR 112014009580A BR 112014009580 A BR112014009580 A BR 112014009580A BR 112014009580 A2 BR112014009580 A2 BR 112014009580A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
omeprazole
omeprazole pharmaceutical
prophylaxis
medicaments
Prior art date
Application number
BR112014009580A
Other languages
English (en)
Other versions
BR112014009580B1 (pt
Inventor
Alcocer Aranzana Cristina
Sangrà Perez Jaume
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of BR112014009580A2 publication Critical patent/BR112014009580A2/pt
Publication of BR112014009580B1 publication Critical patent/BR112014009580B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo composição farmacêutica de omeprazol a presente invenção se refere a composições farmacêuticas sólidas orais compreendendo péletes de omeprazol concentrado, processos para a preparação das mesmas e seu uso como medicamentos, mais particularmente para o tratamento e/ou profilaxia de um distúrbio gastrointestinal.
BR112014009580-9A 2011-11-02 2012-10-31 Composição farmacêutica de omeprazol BR112014009580B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11382336.3 2011-11-02
EP11382336 2011-11-02
PCT/EP2012/071553 WO2013064535A1 (en) 2011-11-02 2012-10-31 Pharmaceutical composition of omeprazole

Publications (2)

Publication Number Publication Date
BR112014009580A2 true BR112014009580A2 (pt) 2017-05-09
BR112014009580B1 BR112014009580B1 (pt) 2022-03-29

Family

ID=47115965

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009580-9A BR112014009580B1 (pt) 2011-11-02 2012-10-31 Composição farmacêutica de omeprazol

Country Status (14)

Country Link
US (1) US20140255503A1 (pt)
EP (1) EP2773348B1 (pt)
AU (1) AU2012331182B2 (pt)
BR (1) BR112014009580B1 (pt)
CA (1) CA2851327C (pt)
ES (1) ES2667402T3 (pt)
HK (1) HK1201477A1 (pt)
HR (1) HRP20180567T1 (pt)
HU (1) HUE036400T2 (pt)
PL (1) PL2773348T3 (pt)
PT (1) PT2773348T (pt)
RU (1) RU2647472C2 (pt)
SI (1) SI2773348T1 (pt)
WO (1) WO2013064535A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US20190125676A1 (en) * 2017-11-02 2019-05-02 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors for oral administration
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
RU2160094C2 (ru) * 1994-07-08 2000-12-10 Астра Актиеболаг Таблетированная многоединичная лекарственная форма, способ ее получения, упаковка и способ ингибирования секреции желудочной кислоты и/или лечения желудочно-кишечных воспалительных заболеваний
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
EP1108425B1 (en) * 1999-12-16 2005-06-08 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles
WO2004016242A2 (en) * 2002-08-16 2004-02-26 Themis Laboratories Private Limited A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
WO2004035052A1 (ja) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
WO2004098573A1 (en) * 2003-05-08 2004-11-18 Natco Pharma Limited An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
CN100490790C (zh) * 2007-04-28 2009-05-27 杭州民生药业集团有限公司 一种奥美拉唑肠溶微丸胶囊及其制备方法
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
CN103402501A (zh) * 2010-12-29 2013-11-20 雷迪博士实验室有限公司 调节释放的苯并咪唑制剂

Also Published As

Publication number Publication date
EP2773348B1 (en) 2018-02-21
CA2851327C (en) 2019-06-25
PT2773348T (pt) 2018-04-16
ES2667402T3 (es) 2018-05-10
SI2773348T1 (en) 2018-05-31
HRP20180567T1 (hr) 2018-05-18
RU2014122135A (ru) 2015-12-10
HK1201477A1 (en) 2015-09-04
US20140255503A1 (en) 2014-09-11
EP2773348A1 (en) 2014-09-10
PL2773348T3 (pl) 2018-07-31
RU2647472C2 (ru) 2018-03-15
BR112014009580B1 (pt) 2022-03-29
HUE036400T2 (hu) 2018-07-30
AU2012331182B2 (en) 2016-05-12
WO2013064535A1 (en) 2013-05-10
AU2012331182A1 (en) 2014-04-17
CA2851327A1 (en) 2013-05-10

Similar Documents

Publication Publication Date Title
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
TN2015000278A1 (en) Autotaxin inhibitors
CL2014002757A1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA020523B9 (ru) Производные хроменона с антиопухолевой активностью
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
BR112014009580A2 (pt) composição farmacêutica de omeprazol
MX340985B (es) Compuestos de n-heteroarilo.
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
MX2012008328A (es) Derivados de pirazina.
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
BR112015010651A2 (pt) composição antiparasitária de amplo espectro de nitazoxanida, probióticos e prebióticos
BR112013024722A2 (pt) compostos de complexo de pirimidina-2-ol-1-óxido de ferro(iii) ou seus sais farmaceuticamente aceitáveis, medicamento e composição
PH12015502703A1 (en) Pharmaceutical compositions
BR112015014917A2 (pt) uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições
BR112015024571A2 (pt) compostos de complexo de ferro(iii), medicamento, e, composição
BR112014015193A2 (pt) composição enriquecida com glicoproteína como um aditivo para alimento e/ou ração e/ou como um agente terapêutico
EA201500366A1 (ru) Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора
MX355103B (es) Composicion para el tratamiento de desordenes inflamatorios e inmunes.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B25D Requested change of name of applicant approved

Owner name: ESTEVE PHARMACEUTICALS, S.A. (ES)

B25G Requested change of headquarter approved

Owner name: ESTEVE PHARMACEUTICALS, S.A. (ES)

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/10/2012, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: TOWA PHARMACEUTICAL EUROPE, S.L. (ES)